- Home
- VCEL vs BLDEW Comparison
VCEL vs BLDEW Comparison
Compare VCEL & BLDEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCEL
- BLDEW
- Stock Information
- Founded
- VCEL 1989
- BLDEW N/A
- Country
- VCEL United States
- BLDEW United States
- Employees
- VCEL N/A
- BLDEW 281
- Industry
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- BLDEW Transportation Services
- Sector
- VCEL Health Care
- BLDEW Consumer Discretionary
- Exchange
- VCEL Nasdaq
- BLDEW Nasdaq
- Market Cap
- VCEL N/A
- BLDEW N/A
- IPO Year
- VCEL 1997
- BLDEW 2019
- Fundamental
- Price
- VCEL $40.95
- BLDEW $0.25
- Analyst Decision
- VCEL Strong Buy
- BLDEW
- Analyst Count
- VCEL 7
- BLDEW 0
- Target Price
- VCEL $55.57
- BLDEW N/A
- AVG Volume (30 Days)
- VCEL 386.0K
- BLDEW N/A
- Earning Date
- VCEL 11-06-2024
- BLDEW N/A
- Dividend Yield
- VCEL N/A
- BLDEW N/A
- EPS Growth
- VCEL N/A
- BLDEW N/A
- EPS
- VCEL 0.01
- BLDEW N/A
- Revenue
- VCEL $214,520,000.00
- BLDEW N/A
- Revenue This Year
- VCEL $23.96
- BLDEW N/A
- Revenue Next Year
- VCEL $25.08
- BLDEW N/A
- P/E Ratio
- VCEL $6,636.14
- BLDEW N/A
- Revenue Growth
- VCEL 20.39
- BLDEW N/A
- 52 Week Low
- VCEL $30.18
- BLDEW N/A
- 52 Week High
- VCEL $54.10
- BLDEW N/A
- Technical
- Relative Strength Index (RSI)
- VCEL 38.97
- BLDEW N/A
- Support Level
- VCEL $40.62
- BLDEW N/A
- Resistance Level
- VCEL $43.58
- BLDEW N/A
- Average True Range (ATR)
- VCEL 1.57
- BLDEW 0.00
- MACD
- VCEL -0.18
- BLDEW 0.00
- Stochastic Oscillator
- VCEL 14.94
- BLDEW 0.00
About BLDEW Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.